Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, recently elected Nancy S. Forster to its Board of Directors.
Read More »The Catalyst for a Cure Vision Restoration Initiative builds on 16 years of seminal scientific research, with an aim to cure glaucoma and restore vision.
Read More »The event was designed to inspire, inform and educate glaucoma patients and their caregivers, providing a unique forum for learning about the latest treatment options and practical tips for living with glaucoma.
Read More »The published UK study suggests Selective Laser Trabeculoplasty should become the principal method for treating patients with glaucoma.
Read More »The FDA has approved Rocklatan, a once-daily IOP-lowering eye drop for patients with open-angle glaucoma, Aerie Pharmaceuticals announced in a press release.
Read More »Glaucoma Research Foundation announced $1 million in annual research grants to support 12 investigators at prestigious universities in the United States, Canada, and Europe.
Read More »The Glaucoma Research Foundation in San Francisco joins eye health organizations and eye care professionals worldwide for World Glaucoma Week, March 10 to 16, 2019.
Read More »For her research project seeking a new treatment to restore vision in glaucoma patients, Adriana Di Polo, PhD, professor of neuroscience at the University of Montreal, was awarded the 2019 Shaffer Prize for Innovative Glaucoma Research.
Read More »National Glaucoma Awareness Month is an important time to spread the word about this sight-stealing disease that affects more than 3 million people in the United States and 60 million worldwide.
Read More »Glaucoma Research Foundation hosted our 2018 Annual Dinner at the historic San Francisco War Memorial and Performing Arts Center on April 24, 2018.
Read More »
